Gossamer Bio, Inc. (GOSS)
USD 0.8
(-7.84%)
USD 0.8
(-7.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -159.15 Million | -187.03 Million | -188.89 Million | -176.36 Million | -144.83 Million | -51.04 Million |
| Net Income | -179.81 Million | -229.37 Million | -234 Million | -243.36 Million | -180.3 Million | -146.96 Million |
| Depreciation & Amortization | 4.38 Million | 4.42 Million | 5.16 Million | 4.26 Million | 3.08 Million | 297 Thousand |
| Deferred income taxes | -3.99 Million | - | 359 Thousand | -158 Thousand | -2.39 Million | - |
| Stock-based compensation | 28.51 Million | 42.55 Million | 32 Million | 38.74 Million | 20.81 Million | 30.94 Million |
| Change in working capital | -14.84 Million | -4.45 Million | 774 Thousand | -3.09 Million | 10.12 Million | 15.02 Million |
| Other non-cash items | 6.58 Million | -177 Thousand | 6.8 Million | 27.23 Million | 3.83 Million | 49.65 Million |
| Investing Cash Flow | -110.97 Million | -1.03 Million | -117.42 Million | 215.34 Million | -147.14 Million | -144.71 Million |
| Investments in PPE | - | -475 Thousand | -1.62 Million | -24.88 Million | -6.56 Million | -21.21 Million |
| Acquisitions | - | -65 Thousand | 75 Thousand | 23.38 Million | 3.6 Million | -17.72 Million |
| Investment purchases | -441.67 Million | -238.06 Million | -152.03 Million | -108.96 Million | -499.07 Million | -123.5 Million |
| Sales/Maturities of investments | 330.7 Million | 237.5 Million | 36.22 Million | 349.19 Million | 358.5 Million | - |
| Other Investing Activities | -110.97 Thousand | 65 Thousand | -75 Thousand | -23.38 Million | -3.6 Million | 17.72 Million |
| Financing Cash Flow | 190.15 Million | 117.09 Million | 3.32 Million | 312.54 Million | 321.57 Million | 300.85 Million |
| Debt repayment | -11.61 Million | -5.8 Million | - | -193.59 Million | -28.22 Million | -40 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 444 Thousand | - | - | - | - | - |
| Common Stock Issuance | 201.76 Million | 119.94 Million | 3.32 Million | 117.11 Million | 291.31 Million | 229.55 Million |
| Other Financing Activities | 201.76 Million | 2.95 Million | 3329.00 | 389.02 Million | 58.48 Million | 300.89 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 3.99 Million | -1.81 Million | -4.42 Million | 6.98 Million | -1.39 Million | 2.08 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -18.83 Million | -2.64 Million | 5.2 Million | -10.07 Million | 11.51 Million | 12.93 Million |
| Cash at beginning of period | 111.97 Million | 183.46 Million | 486.62 Million | 135.08 Million | 105.41 Million | 315 Thousand |
| Cash at end of period | 32.1 Million | 111.97 Million | 183.46 Million | 486.62 Million | 135.08 Million | 105.41 Million |
| Capital Expenditure | - | -475 Thousand | -1.62 Million | -24.88 Million | -6.56 Million | -21.21 Million |
| Effect of forex changes on cash | 110 Thousand | -517 Thousand | -165 Thousand | 9000.00 | 70 Thousand | - |
| Net cash flow / Change in cash | -79.86 Million | -71.49 Million | -303.15 Million | 351.53 Million | 29.67 Million | 105.1 Million |
| Free Cash Flow | -159.15 Million | -187.5 Million | -190.51 Million | -201.24 Million | -151.4 Million | -72.25 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 49.23 Million | -41.92 Million | -48.14 Million | -179.81 Million | -40 Million | -42.49 Million |
| Depreciation & Amortization | 992 Thousand | 986 Thousand | 1 Million | 4.38 Million | 1.08 Million | 1.15 Million |
| Deferred income taxes | - | - | -3.78 Million | -3.99 Million | -2.1 Million | -1.5 Million |
| Stock-based compensation | 5 Million | 5.81 Million | 6.03 Million | 28.51 Million | 6.16 Million | 8.19 Million |
| Change in working capital | 63.79 Million | -14.73 Million | 960 Thousand | -14.84 Million | 77 Thousand | -3.95 Million |
| Other non-cash items | 5.83 Million | 8.26 Million | 10.5 Million | 6.58 Million | 293 Thousand | 353 Thousand |
| Investing Cash Flow | -59.11 Million | 61.67 Million | -14.36 Million | -110.97 Million | -118.26 Million | 12.93 Million |
| Investments in PPE | -116.34 Million | - | 60 Thousand | - | -30 Thousand | -15 Thousand |
| Acquisitions | - | - | -30 Thousand | - | 30 Thousand | 15 Thousand |
| Investment purchases | -193.61 Million | -86.12 Million | -120.26 Million | -441.67 Million | -188.09 Million | -56.44 Million |
| Sales/Maturities of investments | 134.5 Million | 147.8 Million | 105.9 Million | 330.7 Million | 69.8 Million | 69.4 Million |
| Other Investing Activities | -59.11 Million | 61.67 Million | -14.36 Thousand | -110.97 Thousand | 30 Thousand | -15 Thousand |
| Financing Cash Flow | -9.21 Million | -2.55 Million | -2.9 Million | 190.15 Million | 198.49 Million | -2.9 Million |
| Debt repayment | -9.67 Million | -2.9 Million | -2.9 Million | -11.61 Million | -2.9 Million | -2.9 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | 348 Thousand | 77 Thousand | 444 Thousand | - | - |
| Common Stock Issuance | 464 Thousand | 348 Thousand | -444 Thousand | 201.76 Million | 201.4 Million | - |
| Other Financing Activities | 464 Thousand | 348 Thousand | 367 Thousand | 201.76 Million | 201.4 Million | - |
| Accounts receivables | -3.62 Million | - | - | - | - | - |
| Accounts payables | -1.51 Million | -2.92 Million | 4.26 Million | 3.99 Million | -988 Thousand | -507 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 68.94 Million | -11.8 Million | -3.3 Million | -18.83 Million | 1.06 Million | -3.44 Million |
| Cash at beginning of period | 38.86 Million | 32.1 Million | 82.6 Million | 111.97 Million | 37 Million | 65.24 Million |
| Cash at end of period | 86.87 Million | 38.86 Million | 32.1 Million | 32.1 Million | 82.6 Million | 37 Million |
| Capital Expenditure | -116.34 Million | - | 60 Thousand | - | -30 Thousand | -15 Thousand |
| Effect of forex changes on cash | -8000.00 | -62 Thousand | 193 Thousand | 110 Thousand | -136 Thousand | -19 Thousand |
| Net cash flow / Change in cash | 48.01 Million | 6.75 Million | -50.5 Million | -79.86 Million | 45.6 Million | -28.23 Million |
| Free Cash Flow | - | -52.3 Million | -33.36 Million | -159.15 Million | -34.52 Million | -38.26 Million |
7578
4770
AVL
ITX
0L8F
BCT